{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:08:53Z","timestamp":1791295733196,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,21]],"date-time":"2015-10-21T00:00:00Z","timestamp":1445385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,10,21]],"date-time":"2015-10-21T00:00:00Z","timestamp":1445385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although there is evidence that non-steroidal anti-inflammatory drugs (NSAIDs) might be able to prevent pancreatic cancer, the findings from epidemiological studies have been inconsistent. In this paper, we conducted a meta-analysis of observational studies to examine this possibility. We searched PubMed and Embase for observational (cohort or case-control) studies examining the consumption of aspirin and other NSAIDs and the incidence of or mortality rates associated with pancreatic cancer. Twelve studies including approximately 258,000 participants in total were analysed. The administration of aspirin significantly reduced the incidence of pancreatic cancer (8 studies; odds ratio (OR)\u2009=\u20090.77; 95% confidence interval (CI)\u2009=\u20090.62 to 0.96;<jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u200974.2%) but not the mortality associated with it (2 studies; OR\u2009=\u20090.94; 95% CI\u2009=\u20090.73 to 1.22). Specifically, frequent aspirin use was associated with reduced pancreatic cancer incidence (OR\u2009=\u20090.57; 95% CI\u2009=\u20090.39 to 0.83 for high frequency; OR\u2009=\u20090.57; 95% CI\u2009=\u20090.38 to 0.84 for medium frequency). The summary ORs regarding the incidence of pancreatic cancer and either non-aspirin NSAIDs use (OR\u2009=\u20091.08; 95% CI\u2009=\u20090.90 to 1.31) or overall NSAIDs use (OR\u2009=\u20090.97; 95% CI\u2009=\u20090.86 to 1.10) were not significant. In conclusion, aspirin use might reduce the incidence of pancreatic cancer; however, this finding should be interpreted with caution because of study heterogeneity.<\/jats:p>","DOI":"10.1038\/srep15460","type":"journal-article","created":{"date-parts":[[2015,10,21]],"date-time":"2015-10-21T09:53:49Z","timestamp":1445421229000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Aspirin might reduce the incidence of pancreatic cancer: A meta-analysis of observational studies"],"prefix":"10.1038","volume":"5","author":[{"given":"Yan-Peng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Dong","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ling","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Tao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,21]]},"reference":[{"key":"BFsrep15460_CR1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal, A., Siegel, R., Xu, J. & Ward, E. Cancer statistics, 2010. CA Cancer J Clin 60, 277 (2010).","journal-title":"CA Cancer J Clin"},{"key":"BFsrep15460_CR2","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1056\/NEJMoa032295","volume":"350","author":"JP Neoptolemos","year":"2004","unstructured":"Neoptolemos, J. P. et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350, 1200 (2004).","journal-title":"N Engl J Med"},{"key":"BFsrep15460_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.critrevonc.2006.07.001","volume":"61","author":"DJ de Groot","year":"2007","unstructured":"de Groot, D. J., de Vries, E. G., Groen, H. J. & de Jong, S., Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: from lab to clinic. Crit Rev Oncol Hematol 61, 52 (2007).","journal-title":"Crit Rev Oncol Hematol"},{"key":"BFsrep15460_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nrd1034","volume":"2","author":"RJ Flower","year":"2003","unstructured":"Flower, R. J. The development of COX2 inhibitors. Nat Rev Drug Discov 2, 179 (2003).","journal-title":"Nat Rev Drug Discov"},{"key":"BFsrep15460_CR5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jcb.22523","volume":"110","author":"S Ali","year":"2010","unstructured":"Ali, S. et al. Concurrent inhibition of NF-kappaB, cyclooxygenase-2 and epidermal growth factor receptor leads to greater anti-tumor activity in pancreatic cancer. J Cell Biochem 110, 171 (2010).","journal-title":"J Cell Biochem"},{"key":"BFsrep15460_CR6","first-page":"987","volume":"59","author":"ON Tucker","year":"1999","unstructured":"Tucker, O. N. et al. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res 59, 987 (1999).","journal-title":"Cancer Res"},{"key":"BFsrep15460_CR7","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/jnci\/djn485","volume":"101","author":"BF Cole","year":"2009","unstructured":"Cole, B. F. et al. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst 101, 256 (2009).","journal-title":"J Natl Cancer Inst"},{"key":"BFsrep15460_CR8","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1054\/bjoc.2000.1709","volume":"84","author":"SA Khuder","year":"2001","unstructured":"Khuder, S. A. & Mutgi, A. B. Breast cancer and NSAID use: a meta-analysis. Br J Cancer 84, 1188 (2001).","journal-title":"Br J Cancer"},{"key":"BFsrep15460_CR9","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/sj.bjc.6604880","volume":"100","author":"CC Abnet","year":"2009","unstructured":"Abnet, C. C. et al. Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis. Br J Cancer 100, 551 (2009).","journal-title":"Br J Cancer"},{"key":"BFsrep15460_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2407-3-28","volume":"3","author":"A Gonzalez-Perez","year":"2003","unstructured":"Gonzalez-Perez, A., Garcia, R. L. & Lopez-Ridaura, R. Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis. Bmc Cancer 3, 28 (2003).","journal-title":"Bmc Cancer"},{"key":"BFsrep15460_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.cllc.2011.06.009","volume":"13","author":"J Xu","year":"2012","unstructured":"Xu, J. et al. Meta-analysis on the association between nonsteroidal anti-inflammatory drug use and lung cancer risk. Clin Lung Cancer 13, 44 (2012).","journal-title":"Clin Lung Cancer"},{"key":"BFsrep15460_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1741-7015-12-55","volume":"12","author":"Y Liu","year":"2014","unstructured":"Liu, Y. et al. Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis. Bmc Med 12, 55 (2014).","journal-title":"Bmc Med"},{"key":"BFsrep15460_CR13","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/sj.bjc.6600760","volume":"88","author":"S Friis","year":"2003","unstructured":"Friis, S. et al. A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin. Br J Cancer 88, 684 (2003).","journal-title":"Br J Cancer"},{"key":"BFsrep15460_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/jnci\/djh001","volume":"96","author":"ES Schernhammer","year":"2004","unstructured":"Schernhammer, E. S. et al. A prospective study of aspirin use and the risk of pancreatic cancer in women. J Natl Cancer Inst 96, 22 (2004).","journal-title":"J Natl Cancer Inst"},{"key":"BFsrep15460_CR15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/00001648-199403000-00003","volume":"5","author":"DM Schreinemachers","year":"1994","unstructured":"Schreinemachers, D. M. & Everson, R. B. Aspirin use and lung, colon and breast cancer incidence in a prospective study. Epidemiology 5, 138 (1994).","journal-title":"Epidemiology"},{"key":"BFsrep15460_CR16","first-page":"3177","volume":"24","author":"LD Ratnasinghe","year":"2004","unstructured":"Ratnasinghe, L. D. et al. Aspirin use and mortality from cancer in a prospective cohort study. Anticancer Res 24, 3177 (2004).","journal-title":"Anticancer Res"},{"key":"BFsrep15460_CR17","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1093\/jnci\/djh084","volume":"96","author":"EJ Jacobs","year":"2004","unstructured":"Jacobs, E. J. et al. Aspirin use and pancreatic cancer mortality in a large United States cohort. J Natl Cancer Inst 96, 524 (2004).","journal-title":"J Natl Cancer Inst"},{"key":"BFsrep15460_CR18","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/CEJ.0b013e32833b48a4","volume":"19","author":"M Bonifazi","year":"2010","unstructured":"Bonifazi, M. et al. Aspirin use and pancreatic cancer risk. Eur J Cancer Prev 19, 352 (2010).","journal-title":"Eur J Cancer Prev"},{"key":"BFsrep15460_CR19","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1158\/1940-6207.CAPR-11-0146","volume":"4","author":"XL Tan","year":"2011","unstructured":"Tan, X. L. et al. Aspirin, nonsteroidal anti-inflammatory drugs, acetaminophen and pancreatic cancer risk: a clinic-based case-control study. Cancer Prev Res (Phila) 4, 1835 (2011).","journal-title":"Cancer Prev Res (Phila)"},{"key":"BFsrep15460_CR20","doi-asserted-by":"publisher","first-page":"A81","DOI":"10.1136\/gut.2011.239301.166","volume":"60","author":"TFG Pugh","year":"2011","unstructured":"Pugh, T. F. G. et al. Aspirin, NSAIDS, Calcium-channel blockers and statins in the aetiology of pancreatic cancer: preliminary results from a case-control study in two centres in the UK. Gut 60 A81 (2011).","journal-title":"Gut"},{"key":"BFsrep15460_CR21","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1093\/jnci\/94.15.1168","volume":"94","author":"KE Anderson","year":"2002","unstructured":"Anderson, K. E., Johnson, T. W., Lazovich, D. & Folsom, A. R. Association between nonsteroidal anti-inflammatory drug use and the incidence of pancreatic cancer. J Natl Cancer Inst 94, 1168 (2002).","journal-title":"J Natl Cancer Inst"},{"key":"BFsrep15460_CR22","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1158\/1055-9965.EPI-13-1284","volume":"23","author":"SA Streicher","year":"2014","unstructured":"Streicher, S. A., Yu, H., Lu, L., Kidd, M. S. & Risch, H. A. Case-control study of aspirin use and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 23, 1254 (2014).","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFsrep15460_CR23","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1093\/jnci\/djs318","volume":"104","author":"EJ Jacobs","year":"2012","unstructured":"Jacobs, E. J., Newton, C. C., Gapstur, S. M. & Thun, M. J. Daily aspirin use and cancer mortality in a large US cohort. J Natl Cancer Inst 104, 1208 (2012).","journal-title":"J Natl Cancer Inst"},{"key":"BFsrep15460_CR24","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1136\/bmj.320.7250.1642","volume":"320","author":"MJ Langman","year":"2000","unstructured":"Langman, M. J., Cheng, K. K., Gilman, E. A. & Lancashire, R. J. Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. BMJ 320, 1642 (2000).","journal-title":"BMJ"},{"key":"BFsrep15460_CR25","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/sj.bjc.6605636","volume":"102","author":"MC Bradley","year":"2010","unstructured":"Bradley, M. C., Hughes, C. M., Cantwell, M. M., Napolitano, G. & Murray, L. J., Non-steroidal anti-inflammatory drugs and pancreatic cancer risk: a nested case-control study. Br J Cancer 102, 1415 (2010).","journal-title":"Br J Cancer"},{"key":"BFsrep15460_CR26","first-page":"119","volume":"9","author":"PF Coogan","year":"2000","unstructured":"Coogan, P. F. et al. Nonsteroidal anti-inflammatory drugs and risk of digestive cancers at sites other than the large bowel. Cancer Epidemiol Biomarkers Prev 9, 119 (2000).","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFsrep15460_CR27","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1471-2458-2-18","volume":"2","author":"RJ Menezes","year":"2002","unstructured":"Menezes, R. J., Huber, K. R., Mahoney, M. C. & Moysich, K. B. Regular use of aspirin and pancreatic cancer risk. Bmc Public Health 2, 18 (2002).","journal-title":"Bmc Public Health"},{"key":"BFsrep15460_CR28","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1038\/sj.bjc.6600945","volume":"88","author":"HT Sorensen","year":"2003","unstructured":"Sorensen, H. T. et al. Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer 88, 1687 (2003).","journal-title":"Br J Cancer"},{"key":"BFsrep15460_CR29","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1158\/1055-9965.EPI-06-0574","volume":"15","author":"SC Larsson","year":"2006","unstructured":"Larsson, S. C., Giovannucci, E., Bergkvist, L. & Wolk, A. Aspirin and nonsteroidal anti-inflammatory drug use and risk of pancreatic cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15, 2561 (2006).","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFsrep15460_CR30","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/j.1365-2036.2007.03495.x","volume":"26","author":"G Capurso","year":"2007","unstructured":"Capurso, G. et al. Meta-analysis: the use of non-steroidal anti-inflammatory drugs and pancreatic cancer risk for different exposure categories. Aliment Pharmacol Ther 26, 1089 (2007).","journal-title":"Aliment Pharmacol Ther"},{"key":"BFsrep15460_CR31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/MPA.0b013e3182a8d41f","volume":"43","author":"XJ Cui","year":"2014","unstructured":"Cui, X. J. et al. High-dose aspirin consumption contributes to decreased risk for pancreatic cancer in a systematic review and meta-analysis. Pancreas 43, 135 (2014).","journal-title":"Pancreas"},{"key":"BFsrep15460_CR32","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jcin.2008.01.008","volume":"1","author":"EL Hannan","year":"2008","unstructured":"Hannan, E. L. Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations. JACC Cardiovasc Interv 1, 211 (2008).","journal-title":"JACC Cardiovasc Interv"},{"key":"BFsrep15460_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","volume":"377","author":"PM Rothwell","year":"2011","unstructured":"Rothwell, P. M. et al. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 377, 31 (2011).","journal-title":"Lancet"},{"key":"BFsrep15460_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jama.294.1.47","volume":"294","author":"NR Cook","year":"2005","unstructured":"Cook, N. R. et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 294, 47 (2005).","journal-title":"JAMA"},{"key":"BFsrep15460_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-3-642-30331-9_3","volume":"191","author":"M Dovizio","year":"2013","unstructured":"Dovizio, M., Bruno, A., Tacconelli, S. & Patrignani, P. Mode of action of aspirin as a chemopreventive agent. Recent Results Cancer Res 191, 39 (2013).","journal-title":"Recent Results Cancer Res"},{"key":"BFsrep15460_CR36","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.canep.2012.12.002","volume":"37","author":"PG Gobbi","year":"2013","unstructured":"Gobbi, P. G. et al. The prognostic role of time to diagnosis and presenting symptoms in patients with pancreatic cancer. Cancer Epidemiol 37, 186 (2013).","journal-title":"Cancer Epidemiol"},{"key":"BFsrep15460_CR37","doi-asserted-by":"publisher","first-page":"405","DOI":"10.7326\/0003-4819-150-6-200903170-00009","volume":"150","author":"T Wolff","year":"2009","unstructured":"Wolff, T., Miller, T. & Ko, S., Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 150, 405 (2009).","journal-title":"Ann Intern Med"},{"key":"BFsrep15460_CR38","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1161\/CIRCULATIONAHA.105.505636","volume":"113","author":"LK Newby","year":"2006","unstructured":"Newby, L. K. et al. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation 113, 203 (2006).","journal-title":"Circulation"},{"key":"BFsrep15460_CR39","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/nature09515","volume":"467","author":"S Yachida","year":"2010","unstructured":"Yachida, S. et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114 (2010).","journal-title":"Nature"},{"key":"BFsrep15460_CR40","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1056\/NEJMra052717","volume":"353","author":"C Patrono","year":"2005","unstructured":"Patrono, C., Garcia, R. L., Landolfi, R. & Baigent, C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 353, 2373 (2005).","journal-title":"N Engl J Med"},{"key":"BFsrep15460_CR41","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10689-008-9214-8","volume":"8","author":"J Permuth-Wey","year":"2009","unstructured":"Permuth-Wey, J. & Egan, K. M. Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis. Fam Cancer 8, 109 (2009).","journal-title":"Fam Cancer"},{"key":"BFsrep15460_CR42","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher, D., Liberati, A., Tetzlaff, J. & Altman, D. G., Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Plos Med 6, e1000097 (2009).","journal-title":"Plos Med"},{"key":"BFsrep15460_CR43","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang, A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25, 603 (2010).","journal-title":"Eur J Epidemiol"},{"key":"BFsrep15460_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/oxfordjournals.epirev.a036298","volume":"9","author":"S Greenland","year":"1987","unstructured":"Greenland, S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 9, 1 (1987).","journal-title":"Epidemiol Rev"},{"key":"BFsrep15460_CR45","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins, J. P. & Thompson, S. G. Quantifying heterogeneity in a meta-analysis. Stat Med 21, 1539 (2002).","journal-title":"Stat Med"},{"key":"BFsrep15460_CR46","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian, R. & Laird, N. Meta-analysis in clinical trials. Control Clin Trials 7, 177 (1986).","journal-title":"Control Clin Trials"},{"key":"BFsrep15460_CR47","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger, M., Davey, S. G., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629 (1997).","journal-title":"BMJ"},{"key":"BFsrep15460_CR48","doi-asserted-by":"publisher","first-page":"d4002","DOI":"10.1136\/bmj.d4002","volume":"343","author":"JA Sterne","year":"2011","unstructured":"Sterne, J. A. et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 343, d4002 (2011).","journal-title":"BMJ"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep15460.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep15460","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep15460.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T22:25:21Z","timestamp":1718144721000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep15460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,21]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,7]]}},"alternative-id":["BFsrep15460"],"URL":"https:\/\/doi.org\/10.1038\/srep15460","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,21]]},"assertion":[{"value":"31 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15460"}}